Robert O Dillman

7PUBLICATIONS
0CO-AUTHORS
Molecular targetsInnate immunityGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 26, 2025
Double-Blind Randomized Phase 2 Trial Testing Personal Cancer Vaccines in Patients with Advanced Ovarian Cancer.

Lisa N Abaid, Bradley R Corr, Ramez N Eskander

|Nov 21, 2025
A review of vaccinology and ex vivo antigen-loaded dendritic cells: A different approach to infectious disease vaccines.

Robert O Dillman, Gabriel I Nistor, Hans S Keirstead

|Sep 12, 2025
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.

Daniela A Bota, David E Piccioni, Christopher M Duma

|May 03, 2023
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines.

Robert O Dillman, Gabriel I Nistor, Hans S Keirstead

|Aug 26, 2022
A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses.

Gabriel I Nistor, Robert O Dillman, Rockelle M Robles

|Sep 14, 2020
An update on GM-CSF and its potential role in melanoma management.

Robert O Dillman

Pageof 2

Frequent Collaborators